Xylitol and capsular gene expression in Streptococcus pneumoniae

Journal of Medical Microbiology

Volumn 58, Issue 11, 2009, Pages 1470-1473

  Kurola, Paula ^a   Tapiainen, Terhi ^b   Kaijalainen, Tarja ^a   Uhari, Matti ^b   Saukkoriipi, Annika ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN CPSB; UNCLASSIFIED DRUG; XYLITOL;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL CAPSULES; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; CULTURE MEDIA; DOWN-REGULATION; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; OTITIS MEDIA; OTITIS MEDIA WITH EFFUSION; PROTEIN TYROSINE PHOSPHATASES; STREPTOCOCCUS PNEUMONIAE; XYLITOL;

EID: 70350517285     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.011700-0     Document Type: Article

References (23)

1. Eleaume, H. & Jabbouri, S. (2004). Comparison of two standardisation methods in real-time quantitative RT-PCR to follow Staphylococcus aureus genes expression during in vitro growth. J Microbiol Methods 59, 363-370. (Pubitemid 39370798)
2. Hathaway, L. J., Bättig, P. & Mühlemann, K. (2007). In vitro expression of the first capsule gene of Streptococcus pneumoniae, cpsA, is associated with serotype-specific colonization prevalence and invasiveness. Microbiology 153, 2465-2471.
3. Hautalahti, O., Renko, M., Tapiainen, T., Kontiokari, T., Pokka, T. & Uhari, M. (2007). Failure of xylitol given three times a day for preventing acute otitis media. Pediatr Infect Dis J 26, 423-427. (Pubitemid 46789324)
4. Kim, J. O. & Weiser, J. N. (1998). Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis 177, 368-377.
5. Kontiokari, T., Uhari, M. & Koskela, M. (1995). Effect of xylitol on growth of nasopharyngeal bacteria in vitro. Antimicrob Agents Chemother 39, 1820-1823.
6. Kontiokari, T., Uhari, M. & Koskela, M. (1998). Antiadhesive effects of xylitol on otopathogenic bacteria. J Antimicrob Chemother 41, 563-565. (Pubitemid 28230310)
7. Kontiokari, T., Svanberg, M., Mattila, P., Leinonen, M. & Uhari, M. (1999). Quantitative analysis of the effect of xylitol on pneumococcal nasal colonisation in rats. FEMS Microbiol Lett 178, 313-317. (Pubitemid 29412902)
8. LeMessurier, K. S., Ogunniyi, A. D. & Paton, J. C. (2006). Differential expression of key pneumococcal virulence genes in vivo. Microbiology 152, 305-311.
9. -ΔΔCT method. Methods 25, 402-408.
10. Mäkinen, K. K., Bennett, C. A., Hujoel, P. P., Isokangas, P. J., Isotupa, K. P., Pape, H. R., Jr & Mäkinen, P. L. (1995). Xylitol chewing gums and caries rates: a 40-month cohort study. J Dent Res 74, 1904-1913.
11. McEllistrem, M. C., Ransford, J. V. & Khan, S. A. (2007). Characterization of in vitro biofilm-associated pneumococcal phase variants of a clinically relevant serotype 3 clone. J Clin Microbiol 45, 97-101.
12. Morona, J. K., Paton, J. C., Miller, D. C. & Morona, R. (2000). Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae. Mol Microbiol 35, 1431-1442.
13. Morona, J. K., Morona, R., Miller, D. C. & Paton, J. C. (2002). Streptococcus pneumoniae capsule biosynthesis protein CpsB is a novel manganese-dependent phosphotyrosine-protein phosphatase. J Bacteriol 184, 577-583. (Pubitemid 34027401)
14. Morona, J. K., Miller, D. C., Morona, R. & Paton, J. C. (2004). The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae. J Infect Dis 189, 1905-1913. (Pubitemid 38657227)
15. Oggioni, M. R., Trappetti, C., Kadioglu, A., Cassone, M., Iannelli, F., Ricci, S., Andrew, P. W. & Pozzi, G. (2006). Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol Microbiol 61, 1196-1210. (Pubitemid 44215421)
16. Rogers, P. D., Liu, T. T., Barker, K. S., Hilliard, G. M., English, B. K., Thornton, J., Swiatlo, E. & McDaniel, L. S. (2007). Gene expression profiling of the response of Streptococcus pneumoniae to penicillin. J Antimicrob Chemother 59, 616-626. (Pubitemid 47073393)
17. Söderling, E. M., Ekman, T. C. & Taipale, T. J. (2008). Growth inhibition of Streptococcus mutans with low xylitol concentrations. Curr Microbiol 56, 382-385.
18. Tapiainen, T., Kontiokari, T., Sammalkivi, L., Ikäheimo, I., Koskela, M. & Uhari, M. (2001). Effect of xylitol on growth of Streptococcus pneumoniae in the presence of fructose and sorbitol. Antimicrob Agents Chemother 45, 166-169. (Pubitemid 32039109)
19. Tapiainen, T., Renko, M., Kontiokari, T. & Uhari, M. (2002). Xylitol concentrations in the saliva of children after chewing xylitol gum or consuming a xylitol mixture. Eur J Clin Microbiol Infect Dis 21, 53-55. (Pubitemid 34158508)
20. Tapiainen, T., Sormunen, R., Kaijalainen, T., Kontiokari, T., Ikäheimo, I. & Uhari, M. (2004). Ultrastructure of Streptococcus pneumoniae after exposure to xylitol. J Antimicrob Chemother 54, 225-228. (Pubitemid 39028995)
21. Tasara, T. & Stephan, R. (2007). Evaluation of housekeeping genes in Listeria monocytogenes as potential internal control references for normalizing mRNA expression levels in stress adaptation models using real-time PCR. FEMS Microbiol Lett 269, 265-272. (Pubitemid 46449731)
22. Uhari, M., Kontiokari, T., Koskela, M. & Niemelä, M. (1996). Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial. BMJ 313, 1180-1184. (Pubitemid 26381897)
23. Uhari, M., Kontiokari, T. & Niemelä, M. (1998). A novel use of xylitol sugar in preventing acute otitis media. Pediatrics 102, 879-884. (Pubitemid 28462528)